Selective HDAC6 Inhibitor ACY-241, an Oral Tablet, Combined with Pomalidomide and Dexamethasone: Safety and Efficacy of Escalation and Expansion Cohorts in Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma (ACE-MM-200 Study)

Authors :: Niesvizky, Ruben Richardson, Paul G. Yee, Andrew J. Nooka, Ajay K. Raab, Marc S. Shain, Kenneth H. Gabrail, Nashat Y. and Matous, Jeffrey Agarwal, Amit B. Hoffman, James Madan, Sumit Pagel, John M. San Miguel, Jesus Moreau, Philippe and Mateos, Maria-Victoria Facon, Thierry Tamang, David Jones, Simon S. Markelewicz, Jr., Robert J. Wheeler, Catherine and Trede, Nikolaus S. Raje, Noopur Terpos, Evangelos Bensinger, William I.
Publication Year :: 2016

Tools